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Reexpansion pulmonary edema is a rare complication
resulting from rapid emptying of air or liquid from the
pleural cavity performed by either thoracentesis or chest
drainage. Despite being infrequent, mortality may occur in
up to 20% of cases and is attributed to the abrupt reduction
in pleural pressure, especially as a result of extensive
pneumothorax drainage or when there is long-term pul-
monary collapse.1,2
We report the case of a young patient who experienced
intense chest discomfort during thoracentesis for relief of
dyspnea.
CASE DESCRIPTION
A 40-year-old female from Sa˜o Paulo (Brazil) was admitted
for investigation of dyspnea associated with vespertine fever,
loss of weight (4 kg), and arthralgia for 1 month; she denied
other symptoms or comorbidities. Upon physical examina-
tion, only the absence of thoracic–vocal trill and vesicular
breath sounds at the base of the mid-third of the left hemi-
thorax were noteworthy. Breathing ambient air, the periph-
eral oxygen saturation was 88%.
Radiographic assessment revealed a large left pleural
effusion, with no evidence of mediastinal or pulmonary
parenchymal abnormalities. The patient underwent thor-
acentesis (diagnostic and therapeutic) and biopsy of the
parietal pleura with a Cope needle. One liter of citrine
yellow pleural fluid was removed, until thoracentesis had to
be interrupted because of chest pain. With persisting pain, a
chest computed tomography scan was taken, which showed
a persistent mild hydro-pneumothorax on the left hemi-
thorax. No mediastinal abnormalities were noted. The high-
resolution scans showed ipsilateral airspace opacities in the
previously collapsed lung, which consisted of ill-defined
centrilobular micronodules, thickening of interlobular and
intralobular septa, and superimposed patchy ground-glass
opacities predominantly in the lingula and left inferior lobe
with a peripheral and geographic distribution rather than a
gravity-dependent distribution. No abnormalities were
noted in the right lung (Figure 1).
The patient was maintained on spontaneous respiration
with nasal oxygen and, from the second post-puncture day,
she displayed spontaneous and progressive improvement in
the discomfort and the oxygen saturation level.
The pleural fluid analysis showed a lymphocytic exudate
with glucose level of 106 mg/dL, adenosine deaminase of
56 U/L, and negative cultures for pathogens; the oncotic
cytology was negative and the pleural biopsy showed
chronic non-specific pleuritis. The laboratory examinations
and the pleural biopsy established the diagnosis of systemic
lupus erythematous: hand arthritis, pleuritis, and positive
anti-nuclear (1:1280) and anti-Smith (anti-Sm) antibodies.
On the fourth day, before hospital discharge, a new chest
tomography scan showed a decrease in the pneumothorax
and ground-glass opacities. The involution of the parench-
ymal abnormalities allowed us to consider the clinical
picture consistent with post-thoracentesis reexpansion
edema (Figure 2).
DISCUSSION
Pulmonary reexpansion edema may be considered an
iatrogenic complication due to rapid emptying of the
pleural cavity. The incidence referred is less than 1%, and
mortality can reach up to 20%.1,2 The greatest risk affects
young patients with extensive pneumothoraces or pulmon-
ary collapses of more than 7 days’ duration. Included in this
category are patients with large pleural effusions in which
the volume of fluid removed exceeds 3 L.1
The pathophysiological mechanisms are not yet totally
clarified. The main hypothesis considers the existence, after
pulmonary reexpansion, of an acute inflammatory response
that includes damage to the alveolar–capillary membrane
and changes in the pulmonary lymphatic vessels and in the
surfactant resulting from various factors, including reperfu-
sion of a previously collapsed lung.2 Experimental study
has shown that endothelial vascular damage after hypoxic
vasoconstriction induces an increment in the expression of
the inflammatory mediators tumor necrosis factor (TNF)a
and interleukin (IL)-1b.3 In this way, the association of local
and systemic factors explains the bilateral cases of edema
after unilateral manipulation.
Recently, it was investigated whether the ventricular
complacency and the pulmonary capillary pressure can
influence the redistribution of the extravascular lung fluid.4
Nevertheless, even with normal cardiac function and
occlusion pressures of lung capillaries, reexpansion edema
can occur.5 Posteriorly, Sue et al.6 concluded that reexpan-
sion edema after thoracostomy or thoracentesis is essentially
hydrostatic and not a consequence of increased permeability
of the alveolar–capillary barrier. It should be emphasized
that these patients presented no dysfunction of left
chambers or signs of hypervolemia.
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Figure 1 - Computed tomography scans immediately after thoracocentesis showing mild hydro-pneumothorax, ground-glass opacities
predominantly in the lingula and left inferior lobe, centrilobular micronodules, and thickening of interlobular septa.
Figure 2 - Comparative analysis from computed tomography scans. On the left, images immediately after thoracocentesis; on the right,
4 days later. Although a discrete pleural effusion remains on the left, the images show a decrease in the pneumothorax and ground-
glass opacities, consistent with post-thoracentesis reexpansion edema.
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Therefore, current knowledge imputes to the hydrostatic
forces the onset of the edema after acute reexpansion of the
lungs. However, the concomitance of a variable degree of
stress to pulmonary capillaries presupposes damage to the
basement membrane with a consequent production of
cytokines by the vascular endothelium, especially selectin,
generating increased protein permeability.
The clinical picture varies according to the extent of the
edema, but about 64% of patients are symptomatic during
the first hour post-puncture. Suggestive symptoms are
persistent cough (generally for more than 20 min and
regardless of the presence of pinkish sputum), tachycardia,
tachypnea, hypoxemia, and hemodynamic instability.7
The radiographic diagnosis includes the presence of
opacities in the previously collapsed lung, which progresses
over the 2 days following thoracentesis and then rapidly
reverts. Apparently, the tomography pattern of ground-
glass is observed in all patients. Characteristically, the
lesions tend to be peripheral, seen preferentially in gravity-
dependent areas. Additional findings include thickening of
interlobular septa, peribronchovascular band-like thicken-
ings, and poorly defined centrilobular micronodules.
Pleural effusion is not an usual finding.8
Treatment consists of support measures. Lateral decubi-
tus on the affected side is recommended which, in unilateral
cases, contributes to reducing the pulmonary shunt and
improving oxygenation. Noninvasive ventilation should be
considered as good results are obtained, even in serious
cases.9 In patients needing orotracheal intubation and
mechanical ventilation, positive pressure improves symp-
toms after 24–48 h. Asynchronous ventilation is rarely
necessary.
The usefulness of manometry in measuring pleural
pressures during thoracentesis remains controversial, even
when large volumes are drained. Based on animal
studies,10,11 it has been inferred that the procedure should
be interrupted if the pleural pressure drops below
220 cmH20. However, this value is considered conservative,
as healthy individuals can spontaneously generate more
negative pleural pressures with no clinical repercussion.12
At our institution, pleural manometry is used in selected
cases; it is not adopted routinely.
Independent of pressure control, there is no consensus as
to the maximal volume to be drained in a single thoracent-
esis procedure. Feller-Kopman et al.12 reported that, of 185
patients submitted to thoracentesis, only one (0.5%) experi-
enced edema with clinical manifestations, and four (2.2%)
developed compatible radiographic abnormalities. In this
group, the preventive strategy of removing up to 1 L did not
prove to be protective.
In this way, it is currently recognized that the amount of
fluid drained, the pleural pressure, and the elastance are not
predictors of the appearance of edema.11,12 We point out
that there are patients who routinely need drainage of
greater volumes for symptomatic relief of dyspnea, and that
there is not yet a defined limiting value. This fact is
confirmed in the clinical case described, as even the removal
of a moderate volume (1000 mL) provoked reexpansion
edema.
In conclusion, the strategy suggested and applied at our
institution by the Pleura Group is to remove, at the most,
1800 mL (without the use of pleural pressure measure-
ments). The procedure should be interrupted if there is
spontaneous cessation of fluid drainage or if the patient
experiences chest discomfort or persistent cough. These
symptoms have been recognized as correlating with a
reduction in pleural pressure and are indicative of inter-
ruption of the procedure.13
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